TY - JOUR
T1 - The sympathetic nervous system in the 21st century
T2 - Neuroimmune interactions in metabolic homeostasis and obesity
AU - Martinez-Sanchez, Noelia
AU - Sweeney, Owen
AU - Sidarta-Oliveira, Davi
AU - Caron, Alexandre
AU - Stanley, Sarah A.
AU - Domingos, Ana I.
N1 - Funding Information:
N.M.-S. was funded by the European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie Individual Fellowship (grant agreement no. 795891). A.I.D. lab is supported by ERC co-2017 COG 771431; Wellcome/HHMI IRS award 208576/Z/17/Z. AC was supported by funding from the Canada Research Chairs Program, the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and the Cardiometabolic Health, Diabetes and Obesity Research Network. S.A.S. lab is supported by funding from the American Diabetes Association Pathway to Stop Diabetes Grant (ADA #1-17-ACE-31), National Institutes of Health (R01DK124461, R01NS097184), Department of Defense (W81XWH-20-1-0345), and National Science Foundation. All figures were done using BioRender. O.S. rewrote the pre-review version of the manuscript from versions drafted by N.M.-S. for part of the material relating to adipose tissue; S.A.S. for material relating to pancreas; and A.C. for material relating to the liver. O.S. obtained the historical papers from the archive of the Bodleian Library of Oxford University and made pre-review version of Figure 4, which was redrawn by D.S.-O.; S.A.S. made the pre-review version Figure 1, which was redrawn by D.S.-O.; N.M.-S. made the pre-review version of Figure 3; which was expanded, improved, and redrawn by D.S.-O. to meet the reviewer's suggestions; A.C. made the first version of Figure 2; which was redrawn by D.S.-O.; A.I.D. conceptualized the key ideas of the manuscript and coordinated the efforts of all authors. D.S.-O. expanded the sections on CNS control of metabolism, the neuroimmunometabolism section, and made Figures 6, 7, and 8. D.S.-O. A.C. S.A.S. and A.I.D. were involved in the critical appraisal of the literature; and D.S.-O. and A.I.D. played a major role addressing the reviewer's criticisms and shaping the manuscript to the current format. The authors declare no competing interests.
Funding Information:
N.M.-S. was funded by the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie Individual Fellowship (grant agreement no. 795891 ). A.I.D. lab is supported by ERC co-2017 COG 771431 ; Wellcome / HHMI IRS award 208576/Z/17/Z . AC was supported by funding from the Canada Research Chairs Program , the Canadian Institutes of Health Research , the Natural Sciences and Engineering Research Council of Canada , and the Cardiometabolic Health, Diabetes and Obesity Research Network . S.A.S. lab is supported by funding from the American Diabetes Association Pathway to Stop Diabetes Grant ( ADA #1-17-ACE-31 ), National Institutes of Health ( R01DK124461 , R01NS097184 ), Department of Defense ( W81XWH-20-1-0345 ), and National Science Foundation .
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/11/2
Y1 - 2022/11/2
N2 - The sympathetic nervous system maintains metabolic homeostasis by orchestrating the activity of organs such as the pancreas, liver, and white and brown adipose tissues. From the first renderings by Thomas Willis to contemporary techniques for visualization, tracing, and functional probing of axonal arborizations within organs, our understanding of the sympathetic nervous system has started to grow beyond classical models. In the present review, we outline the evolution of these findings and provide updated neuroanatomical maps of sympathetic innervation. We offer an autonomic framework for the neuroendocrine loop of leptin action, and we discuss the role of immune cells in regulating sympathetic terminals and metabolism. We highlight potential anti-obesity therapeutic approaches that emerge from the modern appreciation of SNS as a neural network vis a vis the historical fear of sympathomimetic pharmacology, while shifting focus from post- to pre-synaptic targeting. Finally, we critically appraise the field and where it needs to go.
AB - The sympathetic nervous system maintains metabolic homeostasis by orchestrating the activity of organs such as the pancreas, liver, and white and brown adipose tissues. From the first renderings by Thomas Willis to contemporary techniques for visualization, tracing, and functional probing of axonal arborizations within organs, our understanding of the sympathetic nervous system has started to grow beyond classical models. In the present review, we outline the evolution of these findings and provide updated neuroanatomical maps of sympathetic innervation. We offer an autonomic framework for the neuroendocrine loop of leptin action, and we discuss the role of immune cells in regulating sympathetic terminals and metabolism. We highlight potential anti-obesity therapeutic approaches that emerge from the modern appreciation of SNS as a neural network vis a vis the historical fear of sympathomimetic pharmacology, while shifting focus from post- to pre-synaptic targeting. Finally, we critically appraise the field and where it needs to go.
KW - adipose tissue
KW - leptin
KW - liver
KW - metabolism
KW - neuroimmunology
KW - pancreas
KW - sympathetic neurons
UR - http://www.scopus.com/inward/record.url?scp=85140881690&partnerID=8YFLogxK
U2 - 10.1016/j.neuron.2022.10.017
DO - 10.1016/j.neuron.2022.10.017
M3 - Review article
C2 - 36327900
AN - SCOPUS:85140881690
SN - 0896-6273
VL - 110
SP - 3597
EP - 3626
JO - Neuron
JF - Neuron
IS - 21
ER -